Literature DB >> 17974949

Aneuploidy: instigator and inhibitor of tumorigenesis.

Beth A A Weaver1, Don W Cleveland.   

Abstract

Aneuploidy, an aberrant chromosome number, has been recognized as a common characteristic of cancer cells for more than 100 years and has been suggested as a cause of tumorigenesis for nearly as long. However, this proposal had remained untested due to the difficulty of selectively generating aneuploidy without causing other damage. Using Cenp-E heterozygous animals, which develop whole chromosome aneuploidy in the absence of other defects, we have found that aneuploidy promotes tumorigenesis in some contexts and inhibits it in others. These findings confirm that aneuploidy can act oncogenically and reveal a previously unsuspected role for aneuploidy as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17974949      PMCID: PMC3132555          DOI: 10.1158/0008-5472.CAN-07-2266

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

1.  Unstable kinetochore-microtubule capture and chromosomal instability following deletion of CENP-E.

Authors:  Frances R Putkey; Thorsten Cramer; Mary K Morphew; Alain D Silk; Randall S Johnson; J Richard McIntosh; Don W Cleveland
Journal:  Dev Cell       Date:  2002-09       Impact factor: 12.270

2.  Derivation of human tumor cells in vitro without widespread genomic instability.

Authors:  D Zimonjic; M W Brooks; N Popescu; R A Weinberg; W C Hahn
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

Review 3.  A mutator phenotype in cancer.

Authors:  L A Loeb
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

4.  Aneuploidy acts both oncogenically and as a tumor suppressor.

Authors:  Beth A A Weaver; Alain D Silk; Cristina Montagna; Pascal Verdier-Pinard; Don W Cleveland
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

5.  Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies.

Authors:  R Peto; S Darby; H Deo; P Silcocks; E Whitley; R Doll
Journal:  BMJ       Date:  2000-08-05

6.  Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability.

Authors:  Hyun Jin Shin; Kwan Hyuck Baek; Ae Hwa Jeon; Moon Taek Park; Su Jae Lee; Chang Mo Kang; Hyun Sook Lee; Seong Ho Yoo; Doo Hyun Chung; Young Chul Sung; Frank McKeon; Chang Woo Lee
Journal:  Cancer Cell       Date:  2003-12       Impact factor: 31.743

7.  Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation.

Authors:  J Ramesh Babu; Karthik B Jeganathan; Darren J Baker; Xiaosheng Wu; Ningling Kang-Decker; Jan M van Deursen
Journal:  J Cell Biol       Date:  2003-01-27       Impact factor: 10.539

8.  The yeast nuclear pore complex functionally interacts with components of the spindle assembly checkpoint.

Authors:  Tatiana Iouk; Oliver Kerscher; Robert J Scott; Munira A Basrai; Richard W Wozniak
Journal:  J Cell Biol       Date:  2002-12-09       Impact factor: 10.539

9.  Mitotic checkpoint proteins HsMAD1 and HsMAD2 are associated with nuclear pore complexes in interphase.

Authors:  M S Campbell; G K Chan; T J Yen
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

10.  Centromere-associated protein-E is essential for the mammalian mitotic checkpoint to prevent aneuploidy due to single chromosome loss.

Authors:  Beth A A Weaver; Zahid Q Bonday; Frances R Putkey; Geert J P L Kops; Alain D Silk; Don W Cleveland
Journal:  J Cell Biol       Date:  2003-08-18       Impact factor: 10.539

View more
  89 in total

1.  Evolutionary genomics: When abnormality is beneficial.

Authors:  Judith Berman
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

2.  Linking stem cells to chromosomal instability.

Authors:  Karel H M van Wely; Carlos Martínez-A
Journal:  Oncoimmunology       Date:  2012-03-01       Impact factor: 8.110

Review 3.  Mitosis as an anti-cancer drug target.

Authors:  Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2013-06-18       Impact factor: 4.316

4.  Inducing segmental aneuploid mosaicism in the mouse through targeted asymmetric sister chromatid event of recombination.

Authors:  Arnaud Duchon; Vanessa Besson; Patricia Lopes Pereira; Laetitia Magnol; Yann Hérault
Journal:  Genetics       Date:  2008-08-30       Impact factor: 4.562

5.  Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells.

Authors:  Seth M Taapken; Benjamin S Nisler; Michael A Newton; Tori L Sampsell-Barron; Kimberly A Leonhard; Erik M McIntire; Karen D Montgomery
Journal:  Nat Biotechnol       Date:  2011-04       Impact factor: 54.908

6.  Homeodomain transcription factor and tumor suppressor Prep1 is required to maintain genomic stability.

Authors:  Giorgio Iotti; Elena Longobardi; Silvia Masella; Leila Dardaei; Francesca De Santis; Nicola Micali; Francesco Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-29       Impact factor: 11.205

Review 7.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

8.  miR-125b promotes cell death by targeting spindle assembly checkpoint gene MAD1 and modulating mitotic progression.

Authors:  S Bhattacharjya; S Nath; J Ghose; G P Maiti; N Biswas; S Bandyopadhyay; C K Panda; N P Bhattacharyya; S Roychoudhury
Journal:  Cell Death Differ       Date:  2012-10-26       Impact factor: 15.828

9.  Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity.

Authors:  Darren J Baker; Fang Jin; Karthik B Jeganathan; Jan M van Deursen
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

Review 10.  Whole chromosome instability and cancer: a complex relationship.

Authors:  Robin M Ricke; Janine H van Ree; Jan M van Deursen
Journal:  Trends Genet       Date:  2008-07-31       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.